Skip to main content
. Author manuscript; available in PMC: 2016 May 30.
Published in final edited form as: Nat Biotechnol. 2015 Nov 30;34(1):47–54. doi: 10.1038/nbt.3367

Table 1.

Drugs predicted to influence largest number of immune state changes.

Drug State
changes
Status Drug class
Puromycin 138 Experimental Aminonucleoside antibiotic
Quinostatin 129 Experimental PI3K inhibitor
Deptropine 129 Approved Anti-histamine
Gliclazide 127 Approved Anti-diabetic
Fluspirilene 127 Approved Anti-psychotic
Irinotecan 127 Approved Topoisomerase inhibitor
Pyrvinium 126 Experimental Anti-helmintic
Bepridil 126 Approved Calcium channel blocker
Daunorubicin 126 Approved Anthracycline
Celastrol 125 Experimental Anti-inflammatory
Niclosamide 125 Approved Anti-helmintic
Pimozide 124 Approved Anti-psychotic
HHS Vulnerability Disclosure